Kathleen N Klinzing’s Abstract The immune system can recognize and kill cancer cells. One cell type that excels at this is the cytotoxic T cell, or CD8+ T cell. CD8+ ...

Zachary Walsh’s Abstract T cell immunotherapies, which harness the power of a patient’s own immune system to eliminate tumor cells, are becoming an increasingly pro...

Yingjoy Li’s Abstract Melanoma is the deadliest type of skin cancer. Although it mostly affects people with lighter skin, those with darker skin, including Asian, Asi...

Jordan Bui’s Abstract The use of artificial intelligence (AI) in dermatology is becoming increasingly prevalent and advancing rapidly. Current research has demonstrat...

Jack Kollings’ Abstract Melanoma is an aggressive and potentially deadly form of skin cancer that often resists standard treatments. Recent advances in immunotherapy�...

Kimberly Nguyen’s Abstract Surgical removal of early melanomas has a high survival rate of 98%, but metastasis, the spread of cancer to other sites in the body, bring...

Anjali Devireddy’s Abstract Primary melanoma tumors can have small nests of cancer cells called “microsatellites” neighboring the primary tumor. The prese...

August Culbert’s Abstract Metastatic melanoma remains a significant cause of death in the United States, with average survival rates below 35% just 5 years after init...

Sabrina Bruno’s Abstract When melanoma is not found early, it can get into your blood and lymphatic systems and spread to other parts of your body. When this happens,...

Mayra Betancourt Ponce’s Abstract Metastatic melanoma is the most aggressive and deadliest type of skin cancer. Over the past decades, new therapies targeting mutatio...